1 terminated. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
Follow Glomerulonephritis, IGA: new trials by email Literature Review of Glomerulonephritis, IGA trials Research Report on Glomerulonephritis, IGA
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety Study of of Intravenous CCL2-LPM in Patients With IgA Nephropathy OPL-CCL2-LPM - IGA Nephropathy, Proteinuria | Phase 1 | Terminated | Osprey Pharmaceuticals USA, Inc. | 30 | 2009-03-01 | 2010-06-02 |
Proteinuria (1)
Autoimmune Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Glomerulonephritis (1) · Immune System Diseases (1) · Kidney Diseases (1) · Male Urogenital Diseases (1) · Nephritis (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1) · Urination Disorders (1) · Urogenital Diseases (1) · Urologic Diseases (1) · Urological Manifestations (1)
Osprey Pharmaceuticals USA, Inc. (1)
Canada (1)
Bryan Curtis, M.D. (1) · Michelle Hladunewich, M.D. (1) · Vincent Pichette, M.D., Ph.D. (1)